GO:0070612 histone H2AR3 methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070612 describes the enzymatic activity that transfers a methyl group from S-adenosyl-L-methionine to arginine 3 of histone H2A, producing S-adenosyl-L-homocysteine and methylated H2A.
• This activity is a type of protein arginine methyltransferase (PRMT) reaction and is often associated with PRMT5, which can methylate histone H2A at arginine 3.
• Histone H2AR3 methylation is an epigenetic mark that can influence chromatin structure and gene expression, with roles in cancer and metabolic regulation.
• PRMT5-mediated H2AR3 methylation has been linked to prostate cancer cell growth through androgen receptor activation.
• Inhibition of PRMT5 enhances hepatic mitochondrial biogenesis, suggesting a role for H2AR3 methylation in metabolic control.
• Studying GO:0070612 requires combining enzymatic assays, chromatin immunoprecipitation, and CRISPR-based models to dissect its function.
Description
Histone H2AR3 methyltransferase activity (GO:0070612) is a molecular function that catalyzes the methylation of arginine 3 on histone H2A, using S-adenosyl-L-methionine as the methyl donor. This modification is part of the broader family of protein arginine methylation events that regulate chromatin dynamics and gene transcription. The enzyme responsible for this activity in humans is often PRMT5, which can methylate histone H2A at arginine 3 and other substrates. Understanding this activity is important because it connects epigenetic regulation to diverse biological processes, including cancer progression and mitochondrial function.
histone H2AR3 methyltransferase activity At A Glance
| GO ID | GO:0070612 |
|---|---|
| GO term | histone H2AR3 methyltransferase activity |
| Ontology | molecular_function |
| Synonym | histone-arginine N-methyltransferase activity (H2A-R3 specific); histone H2AR3 arginine methyltransferase activity; histone-H2AR3 methyltransferase activity; histone methylase activity (H2A-R3 specific); histone methyltransferase activity (H2A-R3 specific) |
| Major function | Catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to arginine 3 of histone H2A, producing S-adenosyl-L-homocysteine and methylated H2A. |
| Cofactor | S-adenosyl-L-methionine (SAM) as methyl donor. |
| Reaction | S-adenosyl-L-methionine + (histone H2A)-arginine (position 3) = S-adenosyl-L-homocysteine + (histone H2A)-N-methyl-arginine (position 3). |
| Associated enzyme | Protein arginine methyltransferase 5 (PRMT5) is a known enzyme with this activity. |
What Is GO:0070612?
GO:0070612 is defined as the catalysis of the reaction: S-adenosyl-L-methionine + (histone H2A)-arginine (position 3) = S-adenosyl-L-homocysteine + (histone H2A)-N-methyl-arginine (position 3). In simpler terms, it is the addition of a methyl group to the third arginine residue of histone H2A, a post-translational modification that can alter chromatin structure and function.
Why Is histone H2AR3 methyltransferase activity Important in Cell Biology?
Histone H2AR3 methyltransferase activity is important because it introduces a specific epigenetic mark that can influence gene expression programs, and its dysregulation has been implicated in cancer and metabolic disorders. For researchers, measuring this activity helps link chromatin modifications to cellular phenotypes and provides a target for therapeutic intervention.
• Regulates chromatin structure and accessibility, affecting transcription.
• Modulates androgen receptor signaling in prostate cancer.
• Influences hepatic mitochondrial biogenesis and metabolic homeostasis.
• Serves as a potential biomarker for cancers with altered PRMT5 activity.
• Provides a target for small-molecule inhibitors that block PRMT5-mediated methylation.
• Connects epigenetic regulation to mitochondrial function and energy metabolism.
• Plays a role in cell growth and proliferation in hormone-dependent cancers.
• Can be studied using CRISPR knockout of PRMT5 to assess loss of H2AR3 methylation.
What Happens During histone H2AR3 methyltransferase activity?
Substrate recognition and binding
In simple terms: The enzyme first grabs the histone H2A protein and the methyl donor molecule.
The methyltransferase enzyme, such as PRMT5, binds to histone H2A and to the cofactor S-adenosyl-L-methionine (SAM). This binding positions the target arginine 3 of H2A near the catalytic site for methyl transfer.
Methyl group transfer
In simple terms: A methyl group is moved from SAM onto the arginine residue.
The enzyme catalyzes the transfer of a methyl group from SAM to the guanidino nitrogen of arginine 3 on histone H2A, forming S-adenosyl-L-homocysteine (SAH) and methylated H2A. This reaction is a classic SN2-type methyl transfer common to protein arginine methyltransferases.
Product release and chromatin impact
In simple terms: After methylation, the modified histone can change how DNA is packaged.
Following methyl transfer, SAH is released and the methylated H2A remains part of the nucleosome. The new methyl mark can recruit reader proteins or alter nucleosome stability, thereby influencing gene expression.
Regulation by interacting proteins
In simple terms: Other proteins can help or hinder the enzyme's activity.
PRMT5 often functions in a complex with partner proteins such as MEP50, which can modulate its substrate specificity and activity. This regulation ensures that H2AR3 methylation occurs in a context-dependent manner.
Key Genes Involved in GO:0070612 histone H2AR3 methyltransferase activity
The following genes and proteins are directly or indirectly involved in histone H2AR3 methyltransferase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRMT5 | Catalyzes arginine methylation of histone H2A at R3 and other substrates | Primary enzyme for GO:0070612; target for cancer and metabolic studies |
| MEP50 (WDR77) | Co-factor that associates with PRMT5 to form active methyltransferase complex | Modulates PRMT5 substrate specificity and activity |
| H2A (HIST1H2A family) | Histone substrate for methylation at arginine 3 | Provides the substrate for the reaction; mutations can alter methylation |
| SAM (metabolite) | Methyl donor for the reaction | Essential cofactor; levels affect methylation rate |
| SAH (metabolite) | Product of the reaction; feedback inhibitor | Can inhibit methyltransferase activity; measured in assays |
| Androgen receptor (AR) | Transcription factor activated by PRMT5-mediated methylation | Links H2AR3 methylation to prostate cancer growth |
| PRMT1 | Another arginine methyltransferase with different substrate specificity | Can be used as a comparison in studies of H2AR3 methylation |
| PRMT7 | Arginine methyltransferase that can methylate histones | Potential alternative enzyme for H2A methylation |
| CARMA1 | Not directly linked to H2AR3 methylation | No verified role in this specific activity |
| MEP50 | See WDR77 | Same as above |
| WDR77 | PRMT5 cofactor | Required for efficient H2AR3 methylation |
| H4R3 | Another histone arginine methylation site | Often studied alongside H2AR3 methylation |
| H3R2 | Histone arginine methylation site | Can be used as specificity control |
| H3R8 | Histone arginine methylation site | Can be used as specificity control |
| H3R17 | Histone arginine methylation site | Can be used as specificity control |
| H3R26 | Histone arginine methylation site | Can be used as specificity control |
| H4R3me2s | Symmetric dimethylation mark | Product of PRMT5 activity on H4; related to H2AR3 methylation |
| H2AR3me1 | Monomethylated H2A at R3 | Direct product of GO:0070612; detected by antibodies |
How Is histone H2AR3 methyltransferase activity Regulated?
The activity of histone H2AR3 methyltransferase is regulated by the availability of S-adenosyl-L-methionine, the expression level and post-translational modifications of PRMT5, and its interaction with cofactors such as MEP50. Additionally, metabolic signals that alter SAM/SAH ratios can influence methylation rates. In prostate cancer, androgen receptor signaling can modulate PRMT5 activity, creating a feedback loop that promotes cell growth.
histone H2AR3 methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRMT5 | Prostate cancer | PRMT5 knockout or knockdown in prostate cancer cell lines (e.g., LNCaP) |
| PRMT5 | Hepatic mitochondrial dysfunction | Liver-specific PRMT5 knockout mice or hepatocyte cell lines |
| PRMT5 | Metabolic syndrome | High-fat diet mouse models with PRMT5 inhibition |
| H2A (HIST1H2A) | Chromatin regulation in cancer | H2A R3 point mutant knock-in cell lines |
| Androgen receptor | Prostate cancer growth | AR overexpression or knockout in combination with PRMT5 modulation |
Prostate cancer
PRMT5-mediated methylation of histone H2A at arginine 3 contributes to androgen receptor activation, which drives prostate cancer cell growth. Inhibition of PRMT5 reduces AR signaling and tumor growth in preclinical models.
Metabolic disorders
Inhibition of PRMT5 enhances hepatic mitochondrial biogenesis, suggesting that H2AR3 methylation normally suppresses mitochondrial function in the liver. This links the activity to metabolic diseases such as obesity and type 2 diabetes.
Other cancers
Altered PRMT5 expression and histone arginine methylation are observed in various cancers, though direct evidence for H2AR3 methylation in each cancer type requires further study.
From histone H2AR3 methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PRMT5 reduce H2AR3 methylation? | PRMT5 knockout cell lines generated by CRISPR |
| Does H2A R3 mutation affect chromatin structure? | H2A R3A or R3K point-mutation knock-in cell lines |
| Can H2AR3 methylation be detected in vivo? | Tagged knock-in of H2A with an epitope tag for ChIP |
| Does PRMT5 overexpression increase H2AR3 methylation? | PRMT5 overexpression cell lines |
| What genes are regulated by H2AR3 methylation? | RNA-seq after PRMT5 knockout or inhibition |
| Does H2AR3 methylation affect mitochondrial function? | PRMT5 knockout hepatocytes and mitochondrial assays |
How to Study the histone H2AR3 methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro methyltransferase assay | Enzymatic activity of PRMT5 on H2A | Screening inhibitors or testing mutants |
| Western blot with anti-H2AR3me | Levels of methylated H2A in cells | Assessing changes after drug treatment |
| ChIP-seq | Genomic localization of H2AR3 methylation | Linking mark to gene expression |
| Mass spectrometry | Precise site and degree of methylation | Validating antibody specificity |
| RNA-seq | Transcriptional changes upon PRMT5 perturbation | Identifying downstream pathways |
| CRISPR knockout | Loss-of-function of PRMT5 or other genes | Determining causal role in methylation |
| CRISPR activation (CRISPRa) | Overexpression of PRMT5 | Testing gain-of-function effects |
| Proteomics | Protein interactions with PRMT5 | Identifying cofactors like MEP50 |
Enzymatic assays
In vitro methyltransferase assays using recombinant PRMT5 and histone H2A as substrate can directly measure GO:0070612 activity by detecting incorporation of radiolabeled or fluorescent methyl groups.
Chromatin immunoprecipitation (ChIP)
ChIP with antibodies specific for methylated H2A at R3 can map the genomic distribution of this mark and correlate it with gene expression.
Mass spectrometry
Mass spectrometry of histone extracts can identify and quantify methylation at H2A R3, providing site-specific information.
CRISPR-based screens
Genome-wide CRISPR knockout screens can identify genes that regulate H2AR3 methylation levels, revealing pathways that control this activity.
How CRISPR Can Be Used to Study GO:0070612 histone H2AR3 methyltransferase activity
Knockout
CRISPR knockout of PRMT5 in cell lines abolishes H2AR3 methyltransferase activity, allowing researchers to study downstream effects on chromatin and gene expression. This approach is essential for confirming the enzyme responsible for the mark.
Point Mutation
Introducing point mutations in histone H2A at arginine 3 (e.g., R3A) via CRISPR knock-in prevents methylation at that site, enabling precise dissection of the mark's function without affecting other PRMT5 substrates.
Knock-in
Knock-in of tagged H2A (e.g., HA or FLAG) allows for immunoprecipitation and mapping of methylated H2A in chromatin, facilitating genomic studies.
Overexpression
CRISPR activation or cDNA overexpression of PRMT5 increases H2AR3 methylation levels, which can be used to test gain-of-function phenotypes in cancer and metabolic models.
How EDITGENE Supports histone H2AR3 methyltransferase activity Research
Researchers studying histone H2AR3 methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in the methylation mark or its downstream effects. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for histone H2AR3 methyltransferase activity research.
Frequently Asked Questions About histone H2AR3 methyltransferase activity
What is histone H2AR3 methyltransferase activity?
It is the enzymatic activity that adds a methyl group to arginine 3 of histone H2A, defined as GO:0070612.
What genes are involved in histone H2AR3 methyltransferase activity?
PRMT5 is the primary enzyme, often working with cofactors like MEP50 (WDR77).
Which enzyme catalyzes H2A R3 methylation?
Protein arginine methyltransferase 5 (PRMT5) is known to catalyze this reaction.
What is the role of H2AR3 methylation in cancer?
It can activate androgen receptor signaling in prostate cancer and promote cell growth.
How can I measure histone H2AR3 methyltransferase activity?
In vitro methyltransferase assays, Western blot with specific antibodies, and mass spectrometry are common methods.
What is the relationship between PRMT5 and H2AR3 methylation?
PRMT5 is the enzyme that deposits the methyl mark on H2A R3, and its inhibition reduces the mark.
Can CRISPR be used to study H2AR3 methylation?
Yes, CRISPR knockout of PRMT5 or point mutation of H2A R3 are powerful approaches.
What diseases are associated with H2AR3 methylation?
Prostate cancer and metabolic disorders such as hepatic mitochondrial dysfunction have been linked.
What is the GO definition of histone H2AR3 methyltransferase activity?
It is the catalysis of S-adenosyl-L-methionine + histone H2A arginine 3 to S-adenosyl-L-homocysteine + methylated H2A.
How does H2AR3 methylation affect gene expression?
It can alter chromatin structure and recruit reader proteins, thereby influencing transcription.
Conclusion
Histone H2AR3 methyltransferase activity (GO:0070612) is a key epigenetic modification catalyzed by PRMT5, with important roles in cancer and metabolism. Understanding its regulation and downstream effects requires integrated approaches including CRISPR models, enzymatic assays, and genomic profiling. EDITGENE offers the tools to dissect this activity and its contribution to disease.
References
- 1. Huang L et al.. 2018. Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis.. J Biol Chem 293(28):10884-10894 PMID: 29773653
- 2. Deng X et al.. 2017. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.. Oncogene 36(9):1223-1231 PMID: 27546619
